2022-RA-130-ESGO Ultrasound chemotherapy response assessment in ovarian cancer. (20th October 2022)

• Record Type: Journal Article
• Authors: Elagwany, Ahmed
• Is Part Of: International journal of gynecological cancer. Volume 32(2022)Supplement 2
• Page Start: A221
• Page End: A221
• Publication Date: 2022-10-20
• Subjects: Generative organs, Female -- Cancer -- Periodicals; 616.99465
• DOI: 10.1136/ijgc-2022-ESGO.479
• Languages: English
• ISSNs: 1048-891X

Abstract

Abstract : Introduction/Background: Detection of ovarian malignancies is by transvaginal ultrasound. Currently, the first-line imaging #for staging and assessing disease response in ovarian cancer is computed tomography (CT) of the abdomen and pelvis. However, CT has limitations in mesenteric and small-bowel implants. Ultrasonography by an expert can evaluate the intra-abdominal spread of disease Because of the low cost and high availability. (1) we are describing 2 cases showing common signs on ultrasound to suspect retraction Methodology: Small bowel mesentery root involvement is of great clinical importance because achieving complete cytoreduction is unfeasible. laparoscopic evaluation is undertaken before surgery using the Fagotti score for the small bowel mesentery root. ultrasound can detect that lesion easily based on limited mobility of the intestine, cauliflower mass of the intestine, failure to identify the mesentery individually. Results: US was done revealed multiple implant over ileum & jejunum with mesenteric affection o the small intestine that was detected as limited mobility of the loops of the intestine in the ascites, cawliflower shaped closely packed intestinal loops and limited mobility of the cauliflower mass. Case 2: Ultrasound revealedimited mobility of the intestine on the right side (ileum) than on left side in relation to each other with cauliflower mass appearance with packed closely intestinal loops. Conclusion: Ultrasonography performed by an expert may be a strategy for evaluating the intra-abdominal spread which allows the accurate qualification of patients for PDS or IDS